Edward Tenthoff Recent News
'We're Confident Arrowhead's ARC-520 Is Active Drug For HBV,' Piper Jaffray Says
4 Biotechs Piper Jaffray Is Buying On The Pullback
Baird And Piper Jaffray Love Vertex: Here's Why
UPDATE: Piper Jaffray Downgrades Trius Therapeutics Following Cubist Acquisition
UPDATE: Piper Jaffray Downgrades ISIS Pharmaceuticals on Limited Ownership of Pipeline
UPDATE: Piper Jaffray Downgrades Omthera Pharmaceuticals to Neutral on AstraZeneca Acquisition
Vivus Tumbles 70% on FDA Disapproval; Piper Jaffray Urges You to Buy Arena (ARNA, VVUS)
Piper Jaffray Impressed By New Regeneron Drugs (REGN)
Cytori Therapeutics (NASDAQ: CYTX) Shares Fall On News Of Launch Delay